 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 10/09/2023 |
$0.04 |
$0.05 |
$0.03 |
$0.03 |
2.26M | | 10/10/2023 |
$0.04 |
$0.05 |
$0.03 |
$0.03 |
2.39M | | 10/11/2023 |
$0.03 |
$0.04 |
$0.03 |
$0.04 |
2.44M | | 10/12/2023 |
$0.04 |
$0.04 |
$0.04 |
$0.04 |
1.21M | | 10/13/2023 |
$0.04 |
$0.04 |
$0.03 |
$0.04 |
752.40K |
|
|
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It is developing multiple precision-targeted products based on its Manocept platform to enhance patient care by identifying the sites and pathways of undetected disease. Co.'s business is focused on two primary types of drug products, such as diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform, and therapeutic development programs, including therapeutic applications of its Manocept platform. | |
|
Navidea Biopharmaceuticals (NAVB) has the following price history information. Looking back at NAVB historical stock prices for the last five trading days, on October 09, 2023, NAVB opened at $0.04, traded as high as $0.05 and as low as $0.03, and closed at $0.03. Trading volume was a total of 2.26M shares. On October 10, 2023, NAVB opened at $0.04, traded as high as $0.05 and as low as $0.03, and closed at $0.03. Trading volume was a total of 2.39M shares. On October 11, 2023, NAVB opened at $0.03, traded as high as $0.04 and as low as $0.03, and closed at $0.04. Trading volume was a total of 2.44M shares. On October 12, 2023, NAVB opened at $0.04, traded as high as $0.04 and as low as $0.04, and closed at $0.04. Trading volume was a total of 1.21M shares. On October 13, 2023, NAVB opened at $0.04, traded as high as $0.04 and as low as $0.03, and closed at $0.04. Trading volume was a total of 752.40K shares.
NAVB Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Navidea Biopharmaceuticals shares, starting with a $10,000 purchase of NAVB, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/21/2015 |
|
| End date: |
10/13/2023 |
|
| Start price/share: |
$33.60 |
|
| End price/share: |
$0.04 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.88% |
|
| Average Annual Total Return: |
-53.76% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$11.91 |
|
| Years: |
8.73 |
|
|
|
| Date |
Close |
| 10/09/2023 | $0.03 | | 10/10/2023 | $0.03 | | 10/11/2023 | $0.04 | | 10/12/2023 | $0.04 | | 10/13/2023 | $0.04 |
|
|
Free NAVB Email Alerts:
